€0.61
Your prediction
Financial data and news for CCCC
sharewise wants to provide you with the best news and tools for CCCC, so we directly link to the best financial data sources.
Financials
News
Why C4 Therapeutics Stock Crushed the Market on Monday
C4 Therapeutics (NASDAQ: CCCC) was not only one of the better-performing healthcare stocks on Monday, it was one of the big winners on the market, period. The company seemed to have a rocket
CCCC Revenue Drops 46%
C4 Therapeutics (NASDAQ:CCCC), a clinical-stage biopharmaceutical company specializing in targeted protein degradation therapies, released second quarter results on August 7, 2025. GAAP revenue for


